BIOSYNTHESIS OF RNAS
RNAS的生物合成
基本信息
- 批准号:3484389
- 负责人:
- 金额:$ 47.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1977
- 资助国家:美国
- 起止时间:1977-02-01 至 1995-01-31
- 项目状态:已结题
- 来源:
- 关键词:RNA biosynthesis RNA splicing Saccharomyces cerevisiae adenosine triphosphate alleles conformation evolution fungal genetics genetic transcription guanine nucleotide binding protein immunochemistry lethal genes messenger RNA molecular cloning nucleic acid probes nucleic acid sequence polymerase chain reaction site directed mutagenesis small nuclear ribonucleoproteins spliceosomes temperature sensitive mutant
项目摘要
Our long-term objectives are to exploit the powerful techniques available
in the yeast Saccharymocyes cerevisiae for an understanding of messenger
RNA splicing at the molecular level. Our future work relies on our recent
demonstration of a 1:1 correspondence between five small nuclear RNAs
(snRNAs) in this yeast and mammalian structural organization. One focus of
your program -- motivated by the discovery of group II self-splicing RNAs -
- will be to seek catalytic roles for these snRNAs. We will identify those
residues that are the best candidates for such functions using a combined
genetic, phylogenetic, and biochemical approach. First, structural domains
inferred from phylogenetic comparisons will be deleted and assayed by
complementation of deletion strains. When an essential domain is
identified, its function will be further assessed by inter-species "swaps";
this provides a rapid and rational method of bulk mutagenesis. Finally,
evolutionarily invariant nucleotides in these chimeras will by subjected to
site-specific mutagenesis, to identify change which lead to lethal or,
ideally, conditionally lethal phenotypes. To determine the specific
functional lesion, we will assay the pattern of splicing intermediates in
vivo, and the distribution of spliceosomal complexes within the ordered
assembly pathway in vitro.
The complementary focus of this project is to understand what roles the
spliceosomal proteins play, many of which are known to be essential for
viability. We will explore the hypothesis that at least certain of these
proteins participate in proofreading functions, consistent with the large
number of steps in the spliceosome assembly pathway that require ATP. In
particular, we have cloned and sequenced a nucleotide; rna16-1 has a
consensus ATP binding site and other features of a recently reported
superfamily, members of which include EIF4alpha and a protein required for
mitochondrial mRNA splicing. We propose genetic and biochemical tests of
the model that RNA16 functions in branchpoint recognition to effect an ATP-
dependent conformational switch; by this view, rna16-1 is a "clock mutant"
that acts as a suppressor by decreasing the time allowed for incorrect
splicing substrates to dissociate. This model has important consequences
for elucidating the molecular mechanisms used to maintain biologically
tolerable error rates in complex macromolecular precesses.
我们的长期目标是利用现有的强大技术
在酵母中了解酿酒酵母中的信使
RNA在分子水平上的剪接。我们未来的工作依赖于我们最近的
5个小核RNA之间1:1对应的演示
(SNRNAs)在这种酵母和哺乳动物的结构组织中。关注的焦点之一
你们的计划--以发现第二组自剪接RNA为动力--
-将为这些SnRNA寻求催化作用。我们会找出那些
残基是此类函数的最佳候选者,使用组合的
遗传、系统发育和生化方法。第一,结构性领域
从系统发育比对中推断出来的将被删除并由
缺失菌株的互补性。当一个必要的域是
一旦确定,将通过物种间“互换”进一步评估其功能;
这为大规模诱变提供了一种快速、合理的方法。最后,
这些嵌合体中进化上不变的核苷酸将受到
定点突变,以确定导致致命或,
理想情况下,有条件致死的表型。要确定特定的
功能损伤,我们将分析剪接中间产物在
Vivo,以及剪接体复合体在体内的有序分布
体外组装途径。
本项目的补充重点是了解
剪接体蛋白发挥作用,其中许多已知是必不可少的
生存能力。我们将探索这样一种假设,即至少其中某些
蛋白质参与校对功能,与大的
剪接体组装途径中需要ATP的步骤数。在……里面
特别是,我们已经克隆并测序了一个核苷酸;rna 16-1具有一个
最近报道的一种共识三磷酸腺苷结合位点等特征
超家族,其成员包括EIF4α和一种蛋白质
线粒体mRNAs拼接。我们建议进行遗传和生化测试
RNA16在分支点识别中作用的模型影响ATP-
依赖的构象开关;从这个观点来看,rna 16-1是一个“时钟突变体”
它通过减少错误允许的时间来起到抑制的作用
拼接底物以解离。这种模式具有重要的后果。
为了阐明用于维持生物学的分子机制
复杂大分子过程中可容忍的错误率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTINE GUTHRIE其他文献
CHRISTINE GUTHRIE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTINE GUTHRIE', 18)}}的其他基金
SEARCHING FOR INTERACTORS WITH THE RNA HELICASE SUB2
寻找与 RNA 解旋酶 SUB2 相互作用的蛋白
- 批准号:
6979588 - 财政年份:2004
- 资助金额:
$ 47.81万 - 项目类别:
相似海外基金
Mechanisms of messenger RNA splicing and RNA processing regulation
信使RNA剪接和RNA加工调控机制
- 批准号:
10623834 - 财政年份:2023
- 资助金额:
$ 47.81万 - 项目类别:
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
- 批准号:
2246530 - 财政年份:2023
- 资助金额:
$ 47.81万 - 项目类别:
Standard Grant
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
- 批准号:
2246531 - 财政年份:2023
- 资助金额:
$ 47.81万 - 项目类别:
Standard Grant
Analysis on how RNA splicing factors change global gene expression patterns and regulate male fertility.
分析RNA剪接因子如何改变全局基因表达模式并调节男性生育能力。
- 批准号:
2882792 - 财政年份:2023
- 资助金额:
$ 47.81万 - 项目类别:
Studentship
Aberrant RNA splicing in sporadic inclusion body myositis
散发性包涵体肌炎中的异常RNA剪接
- 批准号:
23K18260 - 财政年份:2023
- 资助金额:
$ 47.81万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
用于选择性靶向RNA剪接因子突变型白血病的合成内含子
- 批准号:
10722782 - 财政年份:2023
- 资助金额:
$ 47.81万 - 项目类别:
Cancer immune therapeutics targeting aberrant RNA splicing products
针对异常 RNA 剪接产物的癌症免疫疗法
- 批准号:
23H02688 - 财政年份:2023
- 资助金额:
$ 47.81万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
RNA splicing regulation during alcohol withdrawal
酒精戒断过程中的 RNA 剪接调节
- 批准号:
10785159 - 财政年份:2023
- 资助金额:
$ 47.81万 - 项目类别:
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
靶向神经退行性疾病中失调的 RNA 剪接
- 批准号:
10729566 - 财政年份:2023
- 资助金额:
$ 47.81万 - 项目类别:
Srsf3-mediated alternative RNA splicing in craniofacial development
Srsf3介导的颅面发育中的选择性RNA剪接
- 批准号:
10650417 - 财政年份:2022
- 资助金额:
$ 47.81万 - 项目类别:














{{item.name}}会员




